{
    "2018-04-24": [
        [
            {
                "time": "2018-04-24",
                "original_text": "Eli Lilly Lures Bain, Advent on Animal Health Sale",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Bain",
                        "Advent",
                        "Animal Health",
                        "Sale"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower",
                "features": {
                    "keywords": [
                        "Dow",
                        "Tumbles",
                        "S&P 500",
                        "Nasdaq",
                        "Lower"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Eli Lilly Tops On Diabetes, Chemo Strength But A Key Drug Lagged",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Diabetes",
                        "Chemo",
                        "Drug",
                        "Lagged"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Stocks Rise as Earnings Propel Wall Street Higher",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Rise",
                        "Earnings",
                        "Wall Street",
                        "Higher"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Eli Lilly's profit beats on strong sales of diabetes, cancer drugs",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "profit",
                        "beats",
                        "diabetes",
                        "cancer drugs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "FDA Advisory Committee Recommends the Approval of Baricitinib 2mg, but not 4mg, for the Treatment of Moderately-to-Severely Active Rheumatoid Arthritis",
                "features": {
                    "keywords": [
                        "FDA",
                        "Baricitinib",
                        "Approval",
                        "Rheumatoid Arthritis"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            }
        ]
    ]
}